185 related articles for article (PubMed ID: 14697422)
1. Influence of hormonal therapy on late rectal function after permanent prostate brachytherapy with or without supplemental external beam radiotherapy.
Merrick GS; Butler WM; Wallner KE; Murray BC; Allen Z; Galbreath RW
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):68-74. PubMed ID: 14697422
[TBL] [Abstract][Full Text] [Related]
2. Late rectal function after prostate brachytherapy.
Merrick GS; Butler WM; Wallner KE; Hines AL; Allen Z
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):42-8. PubMed ID: 12909214
[TBL] [Abstract][Full Text] [Related]
3. Rectal function following prostate brachytherapy.
Merrick GS; Butler WM; Dorsey AT; Galbreath RW; Blatt H; Lief JH
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):667-74. PubMed ID: 11020562
[TBL] [Abstract][Full Text] [Related]
4. Does hormonal manipulation in conjunction with permanent interstitial brachytherapy, with or without supplemental external beam irradiation, improve the biochemical outcome for men with intermediate or high-risk prostate cancer?
Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E
BJU Int; 2003 Jan; 91(1):23-9. PubMed ID: 12614244
[TBL] [Abstract][Full Text] [Related]
5. Rectal function following brachytherapy with or without supplemental external beam radiation: results of two prospective randomized trials.
Merrick GS; Butler WM; Wallner KE; Galbreath RW; Kurko B; Cleavinger S
Brachytherapy; 2003; 2(3):147-57. PubMed ID: 15062137
[TBL] [Abstract][Full Text] [Related]
6. Patient-reported long-term rectal function after permanent interstitial brachytherapy for clinically localized prostate cancer.
Orio PF; Merrick GS; Galbreath RW; Butler WM; Lief J; Wallner KE
Brachytherapy; 2012; 11(5):341-7. PubMed ID: 22561216
[TBL] [Abstract][Full Text] [Related]
7. Long-term rectal function after permanent prostate brachytherapy.
Merrick GS; Butler WM; Wallner KE; Galbreath RW; Allen ZA; Gutman S; Lief J
Cancer J; 2007; 13(2):95-104. PubMed ID: 17476137
[TBL] [Abstract][Full Text] [Related]
8. Androgen deprivation-induced changes in prostate anatomy predict urinary morbidity after permanent interstitial brachytherapy.
Hinerman-Mulroy A; Merrick GS; Butler WM; Wallner KE; Allen Z; Adamovich E
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1367-82. PubMed ID: 15275722
[TBL] [Abstract][Full Text] [Related]
9. Effect of cigarette smoking on biochemical outcome after permanent prostate brachytherapy.
Merrick GS; Butler WM; Wallner KE; Galbreath RW; Lief JH; Adamovich E
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1056-62. PubMed ID: 15001245
[TBL] [Abstract][Full Text] [Related]
10. The impact of prostate volume and neoadjuvant androgen-deprivation therapy on urinary function following prostate brachytherapy.
Merrick GS; Butler WM; Wallner KE; Allen ZA; Lief JH; Hinerman-Mulroy A; Galbreath RW
Cancer J; 2004; 10(3):181-9. PubMed ID: 15285928
[TBL] [Abstract][Full Text] [Related]
11. Erectile function after permanent prostate brachytherapy.
Merrick GS; Butler WM; Galbreath RW; Stipetich RL; Abel LJ; Lief JH
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):893-902. PubMed ID: 11958881
[TBL] [Abstract][Full Text] [Related]
12. High-dose-rate brachytherapy as monotherapy for localized prostate cancer: a retrospective analysis with special focus on tolerance and chronic toxicity.
Yoshioka Y; Nose T; Yoshida K; Oh RJ; Yamada Y; Tanaka E; Yamazaki H; Inoue T; Inoue T
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):213-20. PubMed ID: 12694841
[TBL] [Abstract][Full Text] [Related]
13. Morbidity effect of the time gap between supplemental beam radiation and Pd-103 prostate brachytherapy.
Corriveau J; Wallner K; Merrick G; True L; Cavanagh W; Sutlief S; Butler W
Brachytherapy; 2003; 2(2):108-13. PubMed ID: 15062149
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific antigen spikes after permanent prostate brachytherapy.
Merrick GS; Butler WM; Wallner KE; Galbreath RW; Anderson RL
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):450-6. PubMed ID: 12243821
[TBL] [Abstract][Full Text] [Related]
15. Long-term urinary quality of life after permanent prostate brachytherapy.
Merrick GS; Butler WM; Wallner KE; Galbreath RW; Lief JH
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):454-61. PubMed ID: 12738320
[TBL] [Abstract][Full Text] [Related]
16. Influence of body mass index on biochemical outcome after permanent prostate brachytherapy.
Merrick GS; Butler WM; Wallner KE; Galbreath RW; Allen Z; Lief JH; Adamovich E
Urology; 2005 Jan; 65(1):95-100. PubMed ID: 15667872
[TBL] [Abstract][Full Text] [Related]
17. Quality of life study in prostate cancer patients treated with three-dimensional conformal radiation therapy: comparing late bowel and bladder quality of life symptoms to that of the normal population.
Hanlon AL; Watkins Bruner D; Peter R; Hanks GE
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):51-9. PubMed ID: 11163497
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of radiation dose escalation with conformal external beam radiotherapy and high-dose-rate brachytherapy combined with long-term androgen suppression in unfavorable prostate cancer: feasibility report.
Valero J; Cambeiro M; Galán C; Teijeira M; Romero P; Zudaire J; Moreno M; Ciérvide R; Aristu JJ; Martínez-Monge R
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):386-92. PubMed ID: 19427741
[TBL] [Abstract][Full Text] [Related]
19. Combined modality treatment in the management of high-risk prostate cancer.
Stock RG; Cahlon O; Cesaretti JA; Kollmeier MA; Stone NN
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1352-9. PubMed ID: 15275720
[TBL] [Abstract][Full Text] [Related]
20. The time gap between Pd-103 prostate brachytherapy and supplemental beam radiation does not impact on rectal morbidity or likelihood of cure.
Bittner N; Wallner K; Merrick G; Orio P; Nurani R; True L
Am J Clin Oncol; 2008 Jun; 31(3):231-6. PubMed ID: 18525300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
